Stockscreener 앱 받기
10.27
1.63%
-0.17
시간 외 거래:
10.47
0.20
+1.95%
전일 마감가:
$10.44
열려 있는:
$10.48
하루 거래량:
1.67M
Relative Volume:
0.91
시가총액:
$891.41M
수익:
-
순이익/손실:
$-168.09M
주가수익비율:
-4.7327
EPS:
-2.17
순현금흐름:
$-138.01M
1주 성능:
+5.88%
1개월 성능:
+16.05%
6개월 성능:
+56.55%
1년 성능:
-38.58%
1일 변동 폭
$10.00
$10.62
1주일 범위
$9.80
$11.05
52주 변동 폭
$5.41
$19.73
Kura Oncology Inc Stock (KURA) Company Profile
명칭
Kura Oncology Inc
전화
(858) 500-8800
주소
12730 HIGH BLUFF DRIVE, SUITE 400, SAN DIEGO, CA
KURA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KURA
Kura Oncology Inc
|
10.27 | 906.16M | 0 | -168.09M | -138.01M | -2.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Kura Oncology Inc Stock (KURA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-04 | 개시 | Guggenheim | Neutral |
| 2025-02-06 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-10-24 | 개시 | UBS | Buy |
| 2024-10-14 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-12-22 | 개시 | Mizuho | Buy |
| 2023-08-11 | 개시 | BofA Securities | Buy |
| 2023-07-27 | 개시 | Scotiabank | Sector Perform |
| 2023-05-17 | 개시 | BTIG Research | Buy |
| 2023-01-31 | 개시 | Stifel | Buy |
| 2022-07-12 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-02-15 | 개시 | Jefferies | Buy |
| 2021-05-05 | 재개 | Credit Suisse | Outperform |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2020-12-07 | 재확인 | H.C. Wainwright | Buy |
| 2020-12-03 | 개시 | Stifel | Buy |
| 2020-11-05 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | 개시 | Credit Suisse | Outperform |
| 2020-05-05 | 개시 | Barclays | Overweight |
| 2019-07-18 | 개시 | Deutsche Bank | Buy |
| 2018-11-09 | 개시 | Piper Jaffray | Overweight |
| 2018-08-01 | 개시 | H.C. Wainwright | Buy |
| 2016-10-13 | 재개 | Leerink Partners | Outperform |
| 2016-01-22 | 개시 | JMP Securities | Mkt Outperform |
| 2015-12-30 | 개시 | Oppenheimer | Outperform |
| 2015-12-16 | 개시 | Citigroup | Buy |
모두보기
Kura Oncology Inc 주식(KURA)의 최신 뉴스
Applying sector rotation models to Kura Oncology Inc.July 2025 Movers & Safe Capital Growth Tips - newser.com
Understanding Kura Oncology Inc.’s price movement2025 Market WrapUp & Daily Profit Maximizing Trade Tips - newser.com
Kura Oncology's Ziftomenib Poised For Differentiation (NASDAQ:KURA) - Seeking Alpha
What drives Kura Oncology Inc stock priceGap Up/Gap Down Analysis & Tap Into the Fastest-Growing Companies - earlytimes.in
Signal strength of Kura Oncology Inc. stock in tech scannersPortfolio Growth Summary & Weekly Sector Rotation Insights - newser.com
How Kura Oncology Inc. stock reacts to Fed rate cutsJuly 2025 Sector Moves & Short-Term High Return Ideas - newser.com
What analysts say about Kura Oncology Inc stockGap Up/Gap Down Analysis & Follow Top Performers in the Community - earlytimes.in
Can technical indicators confirm Kura Oncology Inc.’s reversalJuly 2025 Rallies & Target Return Focused Stock Picks - newser.com
What momentum indicators show for Kura Oncology Inc. stockAnalyst Downgrade & Safe Capital Preservation Plans - newser.com
Can Kura Oncology Inc. stock resist market sell offs2025 Retail Activity & Weekly High Return Stock Opportunities - newser.com
Kura Oncology (KURA) to Release Earnings on Thursday - MarketBeat
Kura Oncology Inc. stock momentum explained2025 Price Targets & Low Risk Entry Point Tips - newser.com
Candlestick signals on Kura Oncology Inc. stock todayJuly 2025 Weekly Recap & Verified Momentum Stock Ideas - newser.com
Why Kura Oncology Inc. stock attracts high net worth investorsPortfolio Risk Summary & Safe Swing Trade Setup Alerts - newser.com
Can Kura Oncology Inc. stock rebound after recent weaknessJuly 2025 Short Interest & Capital Efficiency Focused Strategies - newser.com
Is Kura Oncology Inc. showing signs of accumulation2025 Top Gainers & Trade Opportunity Analysis - newser.com
Kura Oncology’s KO-2806 Study: A New Hope for Advanced Solid Tumors? - The Globe and Mail
Kura Oncology (NASDAQ:KURA) Shares Up 9.1%Still a Buy? - MarketBeat
Kura Oncology to Report Third Quarter 2025 Financial Results - The Manila Times
Kura Oncology Inc (KURA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.62%
0.21%
자본화:
|
볼륨(24시간):